Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Screening for minimal hepatic encephalopathy among asymptomatic drivers with chronic liver disease

The Egyptian Journal of Internal Medicine volume 30, pages 217–222 (2018)Cite this article

Abstract

Background and aims

Minimal hepatic encephalopathy (MHE) may impair driving performance and adversely disturbs quality of life. Most drivers with chronic liver disease are not routinely screened for MHE and stay untreated due to the deficiency of standardization of normal values, simple tools, and skills to carry out tests. This study evaluated the usefulness of psychometric tests and critical flicker frequency (CFF) to diagnose MHE among screened drivers with chronic liver disease in Assiut, a city in Upper Egypt.

Patients and methods

A total of 100 drivers with chronic liver disease were screened for MHE. Routine investigations were carried out for all. Psychometric tests including number connection tests A, symbol digits test and CFF testing were applied for them. mini mental state examination questionnaires and Beck’s inventory were carried out for those diagnosed as having MHE.

Results

MHE was found among 40%, with 20 (50%) in Child’s A, 11 (27.5%) in Child’s B, and nine (22.5%) in Child’s C cirrhosis (P=0.027), and 45% of those with MHE had bad driving history. Twelve (12%) patients had abnormal psychometric tests. The sensitivity and specificity of receiver operating characteristic curves for CFF in the diagnosis of MHE was 100%, with a cutoff of less than or equal to 38.5 Hz, and the area under the curve was 1.00 (95% confidence interval, 0.964–1.00) (P<0.0001). There was significant reverse correlation between CFF and Child–Pugh score (r=‒0.271, P=0.030).

Conclusion

Our data revealed a high prevalence of MHE (40%) among drivers with liver cirrhosis. The CFF test is a simple, accurate, and reliable test for diagnosis of MHE, with no age or literacy requirement. Therefore, we suggest to include the CFF test in screening of drivers with chronic liver disease for early discovery and proper management.

References

  1. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 2014; 60:715–735.

    Article  Google Scholar 

  2. Quero JC, Hartmann IJ, Meulstee J, Hop WC, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996; 24:556–560.

    Article  CAS  Google Scholar 

  3. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dolle W. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981; 26:622–630.

    CAS  PubMed  Google Scholar 

  4. Bajaj JS, Etemadian A, Hafeezullah M, Saeian K. Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology 2007; 45:833–834.

    Article  Google Scholar 

  5. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35:716–721.

    Article  Google Scholar 

  6. Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009; 29:629–635.

    Article  Google Scholar 

  7. Weissenborn K, Heidenreich S, Ennen J, Ruckert N, Hecker H. Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis 2001; 16:13–19.

    Article  CAS  Google Scholar 

  8. Sharma K, Pant S, Misra S, Dwivedi M, Misra A, Narang S, et al. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial. Saudi J Gastroenterol 2014; 20:225–232.

    Article  Google Scholar 

  9. Gad YZ, Zaher AA, Moussa NH, El-desoky AE, Al-Adarosy HA. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis. Arab J Gastroenterol 2011; 12:58–61.

    Article  Google Scholar 

  10. Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007; 47:67–73.

    Article  CAS  Google Scholar 

  11. Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007; 102:1903–1909.

    Article  Google Scholar 

  12. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004; 39:739–745.

    Article  Google Scholar 

  13. Kircheis G, Knoche A, Hilger N, Manhart F, Schnitzler A, Schulze H, et al. Hepatic encephalopathy and fitness to drive. Gastroenterology 2009; 137:1706–1715, e1–9.

    Article  Google Scholar 

  14. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16:531–535.

    Article  CAS  Google Scholar 

  15. Romero-Gomez M, Cordoba J, Jover R, del Olmo JA, Ramirez M, Rey R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007; 45:879–885.

    Article  Google Scholar 

  16. Wang JY, Zhang NP, Chi BR, Mi YQ, Meng LN, Liu YD, et al. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China. World J Gastroenterol 2013; 19:4984–4991.

    Article  Google Scholar 

  17. Li SW, Wang K, Yu YQ, Wang HB, Li YH, Xu JM. Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China. World J Gastroenterol 2013; 19:8745–8751.

    Article  Google Scholar 

  18. Ampuero J, Simon M, Montoliu C, Jover R, Serra MA, Cordoba J, et al. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis. Gastroenterology 2015; 149:1483–1489.

    Article  Google Scholar 

  19. Bajaj JS, Ananthakrishnan AN, McGinley EL, Hoffmann RG, Brasel KJ. Deleterious effect of cirrhosis on outcomes after motor vehicle crashes using the nationwide inpatient sample. Am J Gastroenterol 2008; 103:1674–1681.

    Article  Google Scholar 

  20. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007; 132:1261–1269.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University, Egypt

    Mohammad Eltaher Abdelrahman & Saad Zaky Mahmoud

  2. Department of Neurology, Faculty of Medicine, Assiut University, Egypt

    Anwar M. Ali

  3. Department of Tropical Medicine and Gastroenterology, Police Hospital, Egypt

    Haitham Ahmed Abdalla T. El-Khateeb

  4. Department of Internal Medicine, Assiut Faculty of Medicine, Assiut University, 71511, Egypt

    Ghada A. Mohamed MD

Authors
  1. Mohammad Eltaher Abdelrahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saad Zaky Mahmoud
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anwar M. Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Haitham Ahmed Abdalla T. El-Khateeb
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ghada A. Mohamed MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ghada A. Mohamed MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdelrahman, M.E., Mahmoud, S.Z., Ali, A.M. et al. Screening for minimal hepatic encephalopathy among asymptomatic drivers with chronic liver disease. Egypt J Intern Med 30, 217–222 (2018). https://doi.org/10.4103/ejim.ejim_1_18

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_1_18

Keywords